Can you actually stop TRT and restart natural testosterone?

What did @alphaclubsupps actually say?

The creator's main argument is that TRT is not necessarily permanent. He says "99% of the case is if you're on TRT and it's just not for you, you can come off" using post-cycle therapy drugs like clomiphene and tamoxifen (what he calls "Chlamid and Novidek") to restart natural testosterone production. He then pivots to say that if you were genuinely hypogonadal to begin with, coming off just puts you back where you started, so his own answer is "I fucking hope so" when asked if TRT is for life. It's a two-part argument: recovery is possible, but probably pointless if you had real clinical need.

The core message is not wrong, but there are some meaningful gaps in how he frames the ease of PCT, the drugs involved, and what "99% of cases" actually means in a clinical population versus a supplement-community audience where some users may be cycling supraphysiologic doses, not treating diagnosed hypogonadism.

Does the science back this up?

Partially, yes. Testosterone suppression from exogenous testosterone is well-documented and generally reversible in men with previously normal function. But the recovery timeline and completeness are not as clean as "a few weeks and boom, you're back."

A 2020 systematic review by Rastrelli et al. in the Journal of Sexual Medicine found that gonadal axis recovery after testosterone cessation can take anywhere from three months to over two years depending on duration of use, age, and baseline function. A 2011 study by Liu et al. in Journal of Clinical Endocrinology and Metabolism showed that among men who stopped exogenous testosterone, roughly 67% recovered to baseline sperm concentration within 12 months, but a subset took considerably longer. The data on clomiphene citrate as a post-cessation restart is more solid for men with secondary hypogonadism than for those with primary testicular failure. Tamoxifen has supporting data too, but neither drug is FDA-approved specifically for this indication in men, which is worth knowing before someone treats PCT like a guaranteed off-ramp.

What did they get wrong (or right)?

He got the broad concept right: TRT is not automatically a lifetime commitment for every man who tries it, and PCT is a real clinical strategy. Credit for that. He also correctly identifies that men with genuine hypogonadism will likely return to low testosterone after stopping, which is the honest counterpoint that a lot of TRT promoters skip entirely.

What he got wrong is the "99%" figure, which he presents without any basis. That number appears to be invented. Recovery success rates vary considerably by age, cause of hypogonadism, and duration of use. Older men with primary hypogonadism are not bouncing back at 99%. He also mispronounces both drugs ("Chlamid" for clomiphene, "Novidek" for tamoxifen/Nolvadex), which matters less than the fact that he recommends specific drugs without any guidance to consult a prescribing physician. Dropping drug names casually to a 10,000-person TikTok audience without clinical context is a real problem, not just a technicality.

What should you actually know?

If you are on TRT prescribed by a licensed physician for diagnosed hypogonadism, stopping is a medical conversation, not a supplement-stack decision. PCT protocols involving clomiphene or tamoxifen require a prescription, monitoring, and a provider who understands where your baseline actually is.

A few things worth holding onto. First, men who started TRT because of lifestyle-reversible low testosterone (obesity, poor sleep, alcohol use) may have better recovery outcomes than men with structural or age-related hypogonadism. A 2016 paper by Camacho et al. in Clinical Endocrinology found that weight loss alone can meaningfully restore testosterone in obese men with low levels. Second, the creator's framing that PCT is a simple "few weeks" process understates the monitoring required. Hormonal recovery without bloodwork is guesswork. Third, the psychological and physiological effects of returning to low testosterone after experiencing normalized levels can be significant. Patients should know that going back is not emotionally neutral.

The creator's personal enthusiasm for staying on TRT is fine as his own position. It should not function as medical advice for men who have not had a proper diagnostic workup.

Bottom line

This video is more responsible than most TRT content on TikTok in that it acknowledges limitations and doesn't just sell the dream. But the "99%" claim is unsupported, the PCT framing is overly casual, and naming specific prescription drugs to a mass audience without urging physician involvement crosses a line. If you are considering TRT, or considering stopping it, that conversation starts with a licensed clinician and a blood panel, not a DM.